Clinical Trials Directory

Trials / Completed

CompletedNCT06818383

Comparative Study Between Rezum Therapy in Small and Large Prostates

Four-year Follow-up in Rezum Therapy of Small Prostates in Comparison with Large Prostates. a Prospective Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
178 (actual)
Sponsor
khaled Abdelsattar Gad Ibrahim · Academic / Other
Sex
Male
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The investigators aimed to compare the efficacy and safety of Rezūm therapy for the management of benign prostatic hyperplasia (BPH) in small and large prostates.

Detailed description

For decades, Transurethral resection of the prostate (TURP) was the gold standard surgical intervention for small and moderate prostates, however it has high morbidity and prolonged hospital stay Rezūm is a radiofrequency made water vapour thermal treatment. It has recently been added to the international guidelines as a choice for medical treatment resistant lower urinary tract symptoms (LUTS). The AUA and Canadian Urological Association (CUA) guidelines now add water vapour therapy as a treatment option for BPH patients with small prostate size \<80 gm and for those wishing to maintain antegrade ejaculation. While investigators still offer no clear recommendation to Rezūm use for those with large prostates.

Conditions

Interventions

TypeNameDescription
DEVICERezum therapyminimal invasive technique for treating BPH

Timeline

Start date
2021-01-01
Primary completion
2025-01-01
Completion
2025-02-01
First posted
2025-02-10
Last updated
2025-02-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06818383. Inclusion in this directory is not an endorsement.